BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1828673)

  • 1. Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx).
    Lilling G; Beitner R
    Biochem Med Metab Biol; 1991 Jun; 45(3):319-25. PubMed ID: 1828673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy.
    Wehling-Henricks M; Oltmann M; Rinaldi C; Myung KH; Tidball JG
    Hum Mol Genet; 2009 Sep; 18(18):3439-51. PubMed ID: 19542095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in cytoskeleton-bound phosphofructokinase in muscle induced by high intracellular calcium, serotonin and phospholipase A2 in vivo.
    Lilling G; Beitner R
    Int J Biochem; 1990; 22(8):857-63. PubMed ID: 2149116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term streptozotocin diabetes on cytoskeletal and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate and fructose 2,6-bisphosphate in different rat muscles.
    Chen-Zion M; Livnat T; Beitner R
    Biochem Med Metab Biol; 1994 Dec; 53(2):137-44. PubMed ID: 7710770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin-induced hypoglycemia on cytoskeleton-bound and cytosolic phosphofructokinase and the levels of glucose 1,6-bisphosphate in rat brain.
    Magen A; Koren-Schwartzer N; Chen-Zion M; Beitner R
    Biochem Mol Med; 1995 Dec; 56(2):94-8. PubMed ID: 8825070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carbamylcholine and pyridostigmine on cytoskeleton-bound and cytosolic phosphofructokinase and ATP levels in different rat tissues.
    Glass-Marmor L; Chen-Zion M; Beitner R
    Gen Pharmacol; 1996 Oct; 27(7):1241-6. PubMed ID: 8981075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of skeletal muscle in mdx mutant mice.
    De la Porte S; Morin S; Koenig J
    Int Rev Cytol; 1999; 191():99-148. PubMed ID: 10343393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study.
    Grounds MD; McGeachie JK
    Muscle Nerve; 1992 May; 15(5):580-6. PubMed ID: 1584249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy.
    Dye WW; Gleason RL; Wilson E; Humphrey JD
    J Appl Physiol (1985); 2007 Aug; 103(2):664-72. PubMed ID: 17525297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered nuclear dynamics in MDX myofibers.
    Iyer SR; Shah SB; Valencia AP; Schneider MF; Hernández-Ochoa EO; Stains JP; Blemker SS; Lovering RM
    J Appl Physiol (1985); 2017 Mar; 122(3):470-481. PubMed ID: 27979987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptor and calcium leakage activity in nondystrophic and dystrophic myotubes (MDX).
    Carlson CG
    Muscle Nerve; 1996 Oct; 19(10):1258-67. PubMed ID: 8808651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
    Hayes A; Williams DA
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse.
    McIntosh LM; Pernitsky AN; Anderson JE
    Muscle Nerve; 1994 Apr; 17(4):444-53. PubMed ID: 8170492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the muscle plasma membrane-associated cytoskeletons of mdx mice by quick-freeze, deep-etch, rotary-shadow replica method.
    Wakayama Y; Shibuya S
    Acta Neuropathol; 1990; 80(6):618-23. PubMed ID: 2275338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration after free muscle grafting in normal and dystrophic (mdx) mice.
    Moens P; Partridge TA; Morgan JE; Beckers-Bleukx G; Maréchal G
    J Neurol Sci; 1992 Sep; 111(2):209-13. PubMed ID: 1431988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine receptors in innervated muscles of dystrophic mdx mice degrade as after denervation.
    Xu R; Salpeter MM
    J Neurosci; 1997 Nov; 17(21):8194-200. PubMed ID: 9334395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evolution of muscular dystrophy in diaphragm, gastrocnemius and masseter muscles from old male mdx mice.
    Muller J; Vayssiere N; Royuela M; Leger ME; Muller A; Bacou F; Pons F; Hugon G; Mornet D
    J Muscle Res Cell Motil; 2001; 22(2):133-9. PubMed ID: 11519736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice.
    Hayes A; Williams DA
    Am J Physiol; 1998 Apr; 274(4):C1138-44. PubMed ID: 9575811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.